Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today issued the following open letter to STAAR stockholders:

Dear STAAR Surgical Stockholders:

The Special Meeting of Stockholders to vote on the amended agreement with Alcon Inc. (SIX/NYSE: ALC) is just days away. How you vote at the Special Meeting will greatly influence the value of your shares. You have a choice:

• Vote to approve the Alcon agreement and receive the $30.75 per share cash value it provides, which represents a 74% premium to STAAR’s 90-day Volume Weighed Average Price as of August 4, 2025

or

• Risk a future where STAAR’s board, management and strategy are greatly influenced by Broadwood Partners, L.P.’s uninformed views about the challenges facing STAAR’s business

Over the past year, Broadwood has significantly increased its ownership in STAAR and now owns more than 30% of STAAR’s outstanding shares. In addition, Broadwood has repeatedly threatened to run an activist proxy contest to remove three of STAAR’s six directors, which would allow Broadwood to obtain disproportionate influence over STAAR without paying any control premium to STAAR’s other stockholders.

We believe the choice is clear – and strongly recommend that STAAR stockholders vote “FOR” the Alcon merger on the WHITE proxy card TODAY.

THE FACT: Broadwood Has Repeatedly Misled STAAR Stockholders in its Effort to Derail the Alcon Transaction and Serve its Own Creeping Control Agenda

Over the past several months, in an effort to derail the Alcon merger, Broadwood has routinely made fictitious statements regarding supposed third party interest in the Company. In each instance, Broadwood’s claims have been proven false.

Broadwood’s Alleged Third Party Interest	Broadwood’s False Claims	The Facts
Parties A & B	“Two other parties contacted one of STAAR’s directors during the sale process, but the Board did not provide diligence materials or engage with them and did not even invite those parties to submit proposals until hours before the original Merger Agreement was signed.” (Broadwood Partners, L.P. Supplemental Investor Presentation Slide 11)	Two days prior to the August 5, 2025 announcement of the Alcon agreement, STAAR received vague communications of interest from Party A and Party B. Neither party provided any proposal on valuation, timing, diligence requirements, financial capability, transaction structure or other terms. STAAR’s CEO responded within 24 hours of this outreach and invited any proposal, to which none came. During the go-shop period, Party A and B confirmed that neither was interested in receiving information to evaluate a potential transaction.
Party C